Tag Archives: Mirati Therapeutics

Analysts’ View: Wingstop (WING), Mirati Therapeutics (MRTX), Edison (EIX)

Investment Analysts at Stifel upgrade Wingstop Inc. (NASDAQ:WING) shares from Hold to Buy rating while increasing its price target of $80 to $92.

Wingstop Inc., together with its subsidiaries, franchises and operates restaurants under the Wingstop brand name.

*

Brokerage Firm Citigroup upgraded Mirati Therapeutics, Inc. (NASDAQ:MRTX) shares from Neutral to Buy rating while increasing its price target of $76 to $132.

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States.

**

Edison International (NYSE:EIX) shares were upgraded by analysts at UBS from Neutral to Buy rating while increasing its price target of $67 to $72.

Edison International, through its subsidiaries, engages in the generation, transmission, and distribution of electricity in the United States.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/